Up a level |
Hillmen, Peter, Rawstron, Andy C, Brock, Kristian, Muñoz-Vicente, Samuel, Yates, Francesca J, Bishop, Rebecca, Boucher, Rebecca, MacDonald, Donald, Fegan, Christopher, McCaig, Alison et al (show 9 more authors)
(2019)
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.
Journal of Clinical Oncology, 37 (30).
pp. 2722-2730.
Eagle, Gina, Zhuang, Jack ORCID: 0000-0003-3245-0789, Oates, Melanie, Kitteringham, Neil, Herbert, John, Falciani, Francesco ORCID: 0000-0003-1432-2871, Pettitt, Andrew, Park, Kevin, Jenkins, Rosalind, Devereux, Stephen et al (show 2 more authors)
(2017)
Linking genotype to clinical phenotype through proteomic analysis of CLL trial samples.
.
Kennedy, Emma, Coulter, Eve Marie, Halliwell, Emma, Profitos-Peleja, Nuria, Walsby, Elisabeth, Clark, Barnaby, Phillips, Elizabeth H, Burley, Thomas A, Mitchell, Simon, Devereux, Stephen et al (show 13 more authors)
(2021)
TLR9 expression in Chronic Lymphocytic Leukemia identifies a pro-migratory subpopulation and novel therapeutic target.
Blood, 137 (22).
pp. 3064-3078.
Robbe, Pauline, Ridout, Kate E, Vavoulis, Dimitrios V, Dreau, Helene, Kinnersley, Ben, Denny, Nicholas, Chubb, Daniel, Appleby, Niamh, Cutts, Anthony, Cornish, Alex J et al (show 33 more authors)
(2022)
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.
NATURE GENETICS, 54 (11).
1675-+.
Pratt, Guy, Yap, Christina, Oldreive, Ceri, Slade, Daniel, Bishop, Rebecca, Griffiths, Mike, Dyer, Martin JS, Fegan, Chris, Oscier, David, Pettitt, Andrew et al (show 9 more authors)
(2018)
A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.
BRITISH JOURNAL OF HAEMATOLOGY, 182 (3).
pp. 429-433.